Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
5
×
detroit top stories
indiana blog main
indiana top stories
life sciences
medicaid
5
×
medicare
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
eli lilly
nancy pelosi
amgen
bill &
biogen
cancer
deals
democrats
drug price
fda
johnson & johnson
What
drug
plan
price
alzheimer’s
bio
house
prices
roundup
year
administration
anathema
angry
answer
anti
awaited
away
benefited
companies
congress
democrat
democratic
democrats
dems
despite
details
different
discontent
divided
drugs
election
elections
elements
fail
fallout
fear
gene
high
increases
industry
latest
Language
unset
Current search:
medicaid
×
medicare
×
" detroit blog main "
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel